MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$9,756M
Net Income
$1,470M
Net Profit Margin
15.07%
EPS
$1.14
Unit: Million (M) dollars
Revenue Breakdown
Cardiovascular
Neuroscience Group
Medical Surgical
Other Operating Segments Includi...
Revenue Breakdown
US
Total Other Countries Excluding ...
IE
Revenue Breakdown
Electrophysiology Therapies Divi...
Surgical Endoscopy
Cranial And Spinal Technologies ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-07-31
2026-04-24
2026-01-23
2025-10-24
Net sales
9,756
9,808
9,017
8,961
Cost of products sold, excluding amortization of intangible assets
3,416
3,398
3,261
3,061
Research and development expense
771
671
722
754
Selling, general, and administrative expense
3,198
3,057
2,956
2,965
Amortization of intangible assets
412
409
441
463
Restructuring charges, net
72
117
77
10
Certain litigation charges, net
0
25
62
0
Other operating expense (income), net
-123
-259
-35
-22
Operating profit
1,764
1,872
1,464
1,686
Other non-operating expense (income), net
190
138
121
92
Interest expense, net
186
177
181
181
Income before income taxes
1,769
1,833
1,404
1,597
Income tax provision
289
575
254
215
Net income
1,479
1,259
1,150
1,381
Net income attributable to noncontrolling interests
9
17
6
7
Net income attributable to medtronic
1,470
1,244
1,143
1,374
Basic EPS
1.15
0.971
0.89
1.07
Diluted EPS
1.14
0.966
0.89
1.07
Basic Average Shares
1,279,800,000
1,281,000,000
1,282,600,000
1,282,000,000
Diluted Average Shares
1,285,100,000
1,287,800,000
1,289,500,000
1,288,000,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
MDT Income Statement Sankey Diagram
Sankey diagram visualizing MDT income statement for the period
Cardiovascular
$3,927M
(19.54%↑ Y/Y)
Neuroscience Group
$2,678M
(10.84%↑ Y/Y)
Medical Surgical
$2,279M
(9.41%↑ Y/Y)
Revenue From Contract
With Customer...
$8,884M
Other Operating
Segments Including...
$872M
Net sales
$9,756M
(13.73%↑ Y/Y)
Operating profit
$1,764M
(22.08%↑ Y/Y)
Other non-operating
expense (income), net
$190M
(475.76%↑ Y/Y)
Cost of products
sold, excluding...
$3,416M
(13.83%↑ Y/Y)
Selling, general, and
administrative expense
$3,198M
(13.97%↑ Y/Y)
Research and development
expense
$771M
(6.20%↑ Y/Y)
Amortization of intangible
assets
$412M
(-10.24%↓ Y/Y)
Other operating
expense (income), net
-$123M
(-75.71%↓ Y/Y)
Restructuring charges, net
$72M
(60.00%↑ Y/Y)
Income before income
taxes
$1,769M
(35.87%↑ Y/Y)
Interest expense, net
$186M
(5.68%↑ Y/Y)
Net income
$1,479M
(41.26%↑ Y/Y)
Income tax provision
$289M
(13.33%↑ Y/Y)
Net income
attributable to medtronic
$1,470M
(41.35%↑ Y/Y)
Net income
attributable to...
$9M
(28.57%↑ Y/Y)
Buy us a coffee
Medtronic_logo-svg (2)-svg
Medtronic plc (MDT)
Medtronic_logo-svg (2)-svg
Medtronic plc (MDT)
Show more